Because of the significant weight loss component and safety of drug, in 2021, semaglutide was FDA-approved for treating patients who are considered overweight or obese
Medications in this class (e.g., Ozempic, Wegovy, and Mounjaro, which are all brand names for semaglutide and tirzepatide) mimic that hormone
Vagal afferent neurons (VANs) expressing GLP-1Rs innervate intestinal mucosa and hepatic portal vasculature, suggesting these pathways may transduce peripheral GLP-1 RA effects to central satiety and glucoregulatory centers 57,58,59
It wasn't the intended effect of the meds, but one of the side effects was that I lost all interest in food to the point that I'd actually forget to eat (and it also helped with my migraines)
Plateau tip: If your usual routine feels easier than it did when you started losing weight, your body may have adapted to it